COCP
Cocrystal Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.95
−7.20%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 43.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 17.47x
- Price / sales
- 55.26x
- Price / cash flow
- -2.24x
Enterprise value
- Enterprise value
- $17.4M
- EV / sales
- 52.75x
- EV / EBITDA
- -1.76x
- EV / EBIT
- -1.72x
- Market cap
- $18.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026